SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Balaxi Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532597

INE618N01022

24.0912014

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALAXI

24.57

126.15

EPS(TTM)

Face Value()

Div & Yield %

0.93

Back

mpl plastics ltd

Semac Construction reports consolidated net profit of Rs 1.40 crore in the December 2025 quarter

Feb 05,2026

Net profit of Semac Construction reported to Rs 1.40 crore in the quarter ended December 2025 as against net loss of Rs 1.34 crore during the previous quarter ended December 2024. Sales rose 28.03% to Rs 58.96 crore in the quarter ended December 2025 as against Rs 46.05 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	58.96	46.05	28
OPM %	2.58	-2.52	-
PBDT	1.87	-1.91	LP
PBT	1.48	-2.33	LP
NP	1.40	-1.34	LP

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)